Literature DB >> 15375153

Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity.

Nawal M Al-Rasheed1, Ravinder S Chana, Richard J Baines, Gary B Willars, Nigel J Brunskill.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) has key roles in the regulation of adipogenesis, inflammation, and lipid and glucose metabolism. C-peptide is believed to be inert and without appreciable biological functions. Recent studies suggest that C-peptide possesses multiple functions. The present study investigated the effects of insulin and C-peptide on PPARgamma transcriptional activity in opossum kidney proximal tubular cells. Both insulin and C-peptide induced a concentration-dependent stimulation of PPARgamma transcriptional activity. Both agents substantially augmented thiazolidinedione-stimulated PPARgamma transcriptional activity. Neither insulin nor C-peptide had any effect on the expression levels of PPARgamma. GW9662, a PPARgamma antagonist, blocked PPARgamma activation by thiazolidinediones but had no effect on either insulin- or C-peptide-stimulated PPARgamma transcriptional activity. Co-transfection of opossum kidney cells with dominant negative mitogen-activated protein kinase kinase significantly depressed basal PPARgamma transcriptional activity but had no effect on that induced by either insulin or C-peptide. Both insulin- and C-peptide-stimulated PPARgamma transcriptional activity were attenuated by wortmannin and by expression of a dominant negative phosphatidylinositol (PI) 3-kinase p85 regulatory subunit. In addition PI 3-kinase-dependent phosphorylation of PPARgamma was observed after stimulation by C-peptide or insulin. C-peptide effects but not insulin on PPARgamma transcriptional activity were abolished by pertussis toxin pretreatment. Finally both C-peptide and insulin positively control the expression of the PPARgamma-regulated CD36 scavenger receptor in human THP-1 monocytes. We concluded that insulin and C-peptide can stimulate PPARgamma activity in a ligand-independent fashion and that this effect is mediated by PI 3-kinase. These results support a new and potentially important physiological role for C-peptide in regulation of PPARgamma-related cell functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15375153     DOI: 10.1074/jbc.M408268200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia.

Authors:  Jaime Haidet; Vincenza Cifarelli; Massimo Trucco; Patrizia Luppi
Journal:  Inflamm Res       Date:  2011-09-27       Impact factor: 4.575

2.  Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer.

Authors:  Jonathan T Goldstein; Ashton C Berger; Juliann Shih; Fujiko F Duke; Laura Furst; David J Kwiatkowski; Andrew D Cherniack; Matthew Meyerson; Craig A Strathdee
Journal:  Cancer Res       Date:  2017-09-18       Impact factor: 12.701

Review 3.  C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.

Authors:  Corinna Lebherz; Nikolaus Marx
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

4.  Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways.

Authors:  Claire E Hills; Gary B Willars; Nigel J Brunskill
Journal:  Mol Endocrinol       Date:  2010-03-02

5.  Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma.

Authors:  David A Sarruf; Irena Iankova; Anna Abella; Said Assou; Stéphanie Miard; Lluis Fajas
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

6.  Novel Therapeutic Agents in Pediatric Sepsis: Peroxisome Proliferator Receptor γ (PPAR γ) Agonists.

Authors:  Jennifer M Kaplan; Basilia Zingarelli
Journal:  Open Inflamm J       Date:  2011-10-07

7.  Combined zinc supplementation with proinsulin C-peptide treatment decreases the inflammatory response and mortality in murine polymicrobial sepsis.

Authors:  Siarhei Slinko; Giovanna Piraino; Paul W Hake; John R Ledford; Michael O'Connor; Patrick Lahni; Patrick D Solan; Hector R Wong; Basilia Zingarelli
Journal:  Shock       Date:  2014-04       Impact factor: 3.454

8.  C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy.

Authors:  Claire E Hills; Nawal Al-Rasheed; Nouf Al-Rasheed; Gary B Willars; Nigel J Brunskill
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-17

Review 9.  Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.

Authors:  Daniel Walcher; Nikolaus Marx
Journal:  Semin Immunopathol       Date:  2009-04-05       Impact factor: 9.623

Review 10.  Enteral glutamine: a novel mediator of PPARgamma in the postischemic gut.

Authors:  Kechen Ban; Rosemary A Kozar
Journal:  J Leukoc Biol       Date:  2008-04-07       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.